Marjorie Pick
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 7
- Platelet Disorders and Treatments 5
- Pharmacology 11
- Cholinesterase and Neurodegenerative Diseases 9
- Co-authors
- Varda R. Deutsch (17 shared papers)Hermona Soreq (10 shared papers)Amiram Eldor (10 shared papers)Dan Grisaru (10 shared papers)Edouard G. Stanley (3 shared papers)Andrew G. Elefanty (3 shared papers)Lisa Azzola (2 shared papers)Nissim Benvenisty (2 shared papers)
- Journals
- Stem Cells (4 papers)Blood (3 papers)British Journal of Haematology (3 papers)Experimental Hematology (3 papers)PLoS ONE (3 papers)
- Partner nations
- IsraelAustraliaUnited States
In The Last Decade
Marjorie Pick
50 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 97
- Hematology 325
- Genetics 217
- Pharmacology 298
- Molecular Biology 713
- Immunology 158
Countries citing papers authored by Marjorie Pick
This map shows the geographic impact of Marjorie Pick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Pick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Pick more than expected).
Fields of papers citing papers by Marjorie Pick
This network shows the impact of papers produced by Marjorie Pick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Pick. The network helps show where Marjorie Pick may publish in the future.
Co-authors
The 25 scholars most cited alongside Marjorie Pick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 160 | |
| 2 | 2007 | 132 | |
| 3 | 1997 | 121 | |
| 4 | 2001 | 79 | |
| 5 | 2018 | 72 | |
| 6 | 1955 | 67 | |
| 7 | 2002 | 61 | |
| 8 | 2006 | 60 | |
| 9 | 2005 | 51 | |
| 10 | 2013 | 45 | |
| 11 | 2013 | 40 | |
| 12 | 2006 | 40 | |
| 13 | 2004 | 38 | |
| 14 | 2004 | 38 | |
| 15 | 1999 | 36 | |
| 16 | 2008 | 34 | |
| 17 | 2008 | 29 | |
| 18 | 2022 | 27 | |
| 19 | 2011 | 26 | |
| 20 | 2007 | 26 |
About Marjorie Pick
Marjorie Pick is a scholar working on Hematology, Pharmacology, Oncology, Molecular Biology and Genetics, having authored 51 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (9 papers), Multiple Myeloma Research and Treatments (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Platelet Disorders and Treatments (5 papers), Pluripotent Stem Cells Research (5 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Peptidase Inhibition and Analysis (4 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Hematology (325 citations), Genetics (217 citations), Pharmacology (298 citations), Molecular Biology (713 citations) and Immunology (158 citations). Marjorie Pick has collaborated with scholars based in Israel, Australia and United States. Frequent co-authors include Varda R. Deutsch, Hermona Soreq, Amiram Eldor, Dan Grisaru, Edouard G. Stanley, Andrew G. Elefanty, Lisa Azzola, Nissim Benvenisty, Chava Perry and Ori Bar‐Nur. Their work appears in journals such as Stem Cells, Blood, British Journal of Haematology, Experimental Hematology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.